» Authors » Hung-Fu Tseng

Hung-Fu Tseng

Explore the profile of Hung-Fu Tseng including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 53
Citations 686
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Xu S, Sy L, Hong V, Farrington P, Glenn S, Ryan D, et al.
Vaccine . 2024 Feb; 42(7):1731-1737. PMID: 38388239
Background: Although previous studies found no-increased mortality risk after COVID-19 vaccination, residual confounding bias might have impacted the findings. Using a modified self-controlled case series (SCCS) design, we assessed the...
2.
Janoff E, Tseng H, Nguyen J, Alfred T, Vietri J, McDaniel A, et al.
Vaccine . 2023 Jun; 41(31):4571-4578. PMID: 37328350
Background: Persons with Down syndrome (DS) experience an increased risk of pneumonia. We determined the incidence and outcomes of pneumonia and relationship to underlying comorbidities in persons with and without...
3.
Xu S, Huang R, Sy L, Hong V, Glenn S, Ryan D, et al.
Vaccine . 2022 Dec; 41(3):844-854. PMID: 36564276
Background: The safety of COVID-19 vaccines plays an important role in addressing vaccine hesitancy. We conducted a large cohort study to evaluate the risk of non-COVID-19 mortality after COVID-19 vaccination...
4.
Florea A, Sy L, Ackerson B, Qian L, Luo Y, Becerra-Culqui T, et al.
Infect Dis Ther . 2022 Dec; 12(2):411-423. PMID: 36520325
Introduction: This observational retrospective matched cohort study evaluated the safety of a prenatal tetanus, diphtheria, acellular pertussis (Tdap) vaccination, Boostrix. We previously reported on the risk of maternal and neonatal...
5.
Nelson J, Ulloa-Perez E, Yu O, Cook A, Jackson M, Belongia E, et al.
Am J Epidemiol . 2022 Oct; 192(2):205-216. PMID: 36193854
Recombinant zoster vaccine (RZV) (Shingrix; GlaxoSmithKline, Brentford, United Kingdom) is an adjuvanted glycoprotein vaccine that was licensed in 2017 to prevent herpes zoster (shingles) and its complications in older adults....
6.
Ackerson B, Bruxvoort K, Qian L, Sy L, Tseng H
J Infect Dis . 2022 Jul; 227(3):466-467. PMID: 35880546
No abstract available.
7.
Xu S, Huang R, Sy L, Glenn S, Ryan D, Morrissette K, et al.
MMWR Morb Mortal Wkly Rep . 2021 Oct; 70(43):1520-1524. PMID: 34710075
By September 21, 2021, an estimated 182 million persons in the United States were fully vaccinated against COVID-19.* Clinical trials indicate that Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273), and Janssen (Johnson &...
8.
Ackerson B, Tseng H
J Infect Dis . 2020 Nov; 224(3):554-555. PMID: 33244580
No abstract available.
9.
Patterson B, Herring W, Van Oorschot D, Curran D, Carrico J, Zhang Y, et al.
J Manag Care Spec Pharm . 2020 Oct; 26(12):1567-1575. PMID: 33043821
Background: In 2017, the FDA approved the adjuvanted recombinant zoster vaccine (RZV) for the prevention of herpes zoster (HZ) in immunocompetent adults aged 50 years and older. RZV joined zoster...
10.
Hause A, Panagiotakopoulos L, Weintraub E, Sy L, Glenn S, Tseng H, et al.
Clin Infect Dis . 2020 Jun; 72(1):138-140. PMID: 32484508
We identified 10 women hospitalized with respiratory syncytial virus infection during pregnancy. Diagnoses included pneumonia/atelectasis (5), respiratory failure (2), and sepsis (2). Six had obstetrical complications during hospitalization, including 1...